vs

Side-by-side financial comparison of Strive, Inc. (ASST) and Anteris Technologies Global Corp. (AVR). Click either name above to swap in a different company.

Anteris Technologies Global Corp. is the larger business by last-quarter revenue ($310.0K vs $255.0K, roughly 1.2× Strive, Inc.). Anteris Technologies Global Corp. runs the higher net margin — -9420.0% vs -75406.7%, a 65986.7% gap on every dollar of revenue.

Strive Asset Management is an American investment management firm founded in 2022. The firm operates mutual funds, exchange-traded products (ETPs), and wealth management services. Headquartered in Columbus, Ohio, it operates as a subsidiary of Strive Enterprises, Inc. and is registered with the U.S. Securities and Exchange Commission (SEC) as an investment adviser.

Anteris Technologies Global Corp is a medical technology firm specializing in innovative structural heart care solutions. It develops and commercializes bioprosthetic heart valves and transcatheter intervention products, serving healthcare providers across North America, Europe, and Asia-Pacific, with core focus on cardiac surgery and interventional cardiology segments.

ASST vs AVR — Head-to-Head

Bigger by revenue
AVR
AVR
1.2× larger
AVR
$310.0K
$255.0K
ASST
Higher net margin
AVR
AVR
65986.7% more per $
AVR
-9420.0%
-75406.7%
ASST

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
ASST
ASST
AVR
AVR
Revenue
$255.0K
$310.0K
Net Profit
$-192.3M
$-29.2M
Gross Margin
70.6%
Operating Margin
-17288.6%
-9343.5%
Net Margin
-75406.7%
-9420.0%
Revenue YoY
-74.1%
Net Profit YoY
-2726.9%
EPS (diluted)
$-0.22
$-0.74

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASST
ASST
AVR
AVR
Q4 25
$310.0K
Q3 25
$255.0K
$429.0K
Q2 25
$173.3K
$618.0K
Q1 25
$170.7K
$556.0K
Q4 24
$212.8K
Q3 24
$984.0K
Q2 24
$93.0K
Q1 24
$124.8K
Net Profit
ASST
ASST
AVR
AVR
Q4 25
$-29.2M
Q3 25
$-192.3M
$-22.2M
Q2 25
$-8.9M
$-20.8M
Q1 25
$-3.7M
$-21.9M
Q4 24
$-4.1M
Q3 24
$-6.8M
Q2 24
$-5.9M
Q1 24
$-4.8M
Gross Margin
ASST
ASST
AVR
AVR
Q4 25
70.6%
Q3 25
71.3%
Q2 25
76.1%
Q1 25
62.8%
Q4 24
Q3 24
Q2 24
Q1 24
Operating Margin
ASST
ASST
AVR
AVR
Q4 25
-9343.5%
Q3 25
-17288.6%
-5190.0%
Q2 25
-1553.9%
-3379.3%
Q1 25
-970.5%
-3917.3%
Q4 24
-5889.5%
Q3 24
-712.4%
Q2 24
-1857.2%
Q1 24
-1110.9%
Net Margin
ASST
ASST
AVR
AVR
Q4 25
-9420.0%
Q3 25
-75406.7%
-5185.1%
Q2 25
-5122.4%
-3371.2%
Q1 25
-2195.6%
-3932.4%
Q4 24
-1935.5%
Q3 24
-691.3%
Q2 24
-6313.1%
Q1 24
-3837.7%
EPS (diluted)
ASST
ASST
AVR
AVR
Q4 25
$-0.74
Q3 25
$-0.22
$-0.62
Q2 25
$-0.17
$-0.58
Q1 25
$-0.13
$-0.61
Q4 24
$-5.62
Q3 24
$-3.06
Q2 24
$-0.58
Q1 24
$-0.49

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASST
ASST
AVR
AVR
Cash + ST InvestmentsLiquidity on hand
$109.1M
Total DebtLower is stronger
$22.0K
Stockholders' EquityBook value
$779.4M
$-93.0K
Total Assets
$792.6M
$23.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASST
ASST
AVR
AVR
Q4 25
Q3 25
$109.1M
Q2 25
$2.5M
Q1 25
$4.2M
$49.0M
Q4 24
$6.2M
Q3 24
$2.1M
Q2 24
$1.9M
Q1 24
$1.9M
Total Debt
ASST
ASST
AVR
AVR
Q4 25
$22.0K
Q3 25
$26.0K
Q2 25
$30.0K
Q1 25
$30.0K
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ASST
ASST
AVR
AVR
Q4 25
$-93.0K
Q3 25
$779.4M
$3.7M
Q2 25
$10.7M
$24.4M
Q1 25
$19.6M
$43.3M
Q4 24
$23.3M
Q3 24
$27.5M
Q2 24
$5.4M
Q1 24
$11.3M
Total Assets
ASST
ASST
AVR
AVR
Q4 25
$23.0M
Q3 25
$792.6M
$19.1M
Q2 25
$3.3M
$39.9M
Q1 25
$5.0M
$58.8M
Q4 24
$28.2M
Q3 24
$2.6M
Q2 24
$2.4M
Q1 24
$2.1M
Debt / Equity
ASST
ASST
AVR
AVR
Q4 25
Q3 25
0.01×
Q2 25
0.00×
Q1 25
0.00×
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASST
ASST
AVR
AVR
Operating Cash FlowLast quarter
$-14.0M
$-18.5M
Free Cash FlowOCF − Capex
$-18.9M
FCF MarginFCF / Revenue
-6104.5%
Capex IntensityCapex / Revenue
0.0%
128.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-79.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASST
ASST
AVR
AVR
Q4 25
$-18.5M
Q3 25
$-14.0M
$-18.3M
Q2 25
$-1.7M
$-19.5M
Q1 25
$-1.6M
$-21.5M
Q4 24
$-21.6M
Q3 24
$-13.2M
Q2 24
$-1.3M
Q1 24
$-1.0M
Free Cash Flow
ASST
ASST
AVR
AVR
Q4 25
$-18.9M
Q3 25
$-19.0M
Q2 25
$-20.1M
Q1 25
$-21.7M
Q4 24
$-21.6M
Q3 24
$-13.4M
Q2 24
$-1.3M
Q1 24
$-1.1M
FCF Margin
ASST
ASST
AVR
AVR
Q4 25
-6104.5%
Q3 25
-4434.5%
Q2 25
-3247.9%
Q1 25
-3909.5%
Q4 24
-10161.2%
Q3 24
-1360.3%
Q2 24
-1379.4%
Q1 24
-844.7%
Capex Intensity
ASST
ASST
AVR
AVR
Q4 25
128.1%
Q3 25
0.0%
180.0%
Q2 25
86.9%
Q1 25
44.6%
Q4 24
11.3%
Q3 24
18.8%
Q2 24
3.1%
Q1 24
9.5%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons